Qiagen N.V. (QGEN)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Qiagen N.V. (“Qiagen” or “the Company”) (NYSE: QGEN). Investors who purchased Qiagen securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Qiagen has violated federal securities laws.
Qiagen Investigation Details
Qiagen claimed in its February 5, 2026, earnings call, that QuantiFERON would accelerate to achieve “between 6% and 7% growth” in 2026. The Company presented very different guidance on April 28, 2026, when its CFO revealed that sales were projected to “continue at a largely unchanged level from the second quarter of ’25,” and that QuantiFERON would “return… to a more normalized growth rate in ’27.” Following this news, Qiagen’s stock price dropped.
What’s Next for Qiagen Investors?
If you are aware of any facts relating to this investigation or purchased Qiagen securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Qiagen Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC For Qiagen Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace,” said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.